Publication | Closed Access

Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway

Acute Lung InjuryInflammationAnti-inflammatoryInflammatory Lung DiseaseLps-treated MiceLung InflammationMedicineImmunologyChronic InflammationPulmonary PharmacologyPulmonary FibrosisNf-κb PathwayPharmacologyInflammatory DiseasePulmonary Disease